Company Filing History:
4 out of 5 
3 out of 12 
1 out of 43 
Years Active: 2001-2007
Title: Igor Zaltzman: Innovator in Prostaglandin Derivatives
Introduction
Igor Zaltzman is a prominent inventor based in Haifa, Israel. He has made significant contributions to the field of chemistry, particularly in the development of prostaglandin derivatives. With a total of 9 patents to his name, Zaltzman's work has had a notable impact on pharmaceutical advancements.
Latest Patents
Zaltzman's latest patents include a novel process for the preparation of prostaglandin derivatives. This invention provides a new method for synthesizing prostaglandins and their analogues, along with new crystalline intermediates. Another significant patent is for the process of preparing 17-phenyl-18,19,20-thinor-PGF2a and its derivatives. This invention offers an effective synthesis process for anti-glaucoma drugs such as Bimatoprost and Latanoprost. The innovative aspect of this process lies in the ability to isolate a major intermediate from a mixture containing an undesired isomer through crystallization.
Career Highlights
Throughout his career, Igor Zaltzman has worked with notable companies, including Finetech Laboratories Ltd. and Fine Tech Corporation. His expertise in the field has allowed him to contribute to various projects and advancements in pharmaceutical chemistry.
Collaborations
Zaltzman has collaborated with esteemed colleagues such as Arie L Gutman and Genady Nisnevich. These partnerships have further enriched his research and development efforts.
Conclusion
Igor Zaltzman's innovative work in the field of prostaglandin derivatives showcases his dedication to advancing pharmaceutical science. His contributions continue to influence the development of important medical treatments.